Between President Trump on Twitter and critics in Congress, pharma and its pricing faced daily fire last year. But the industry’s top lobbyists shot back—and shelled out a record amount of cash to do it.
Between President Trump on Twitter and critics in Congress, pharma and its pricing faced daily fire last year. But the industry’s top lobbyists shot back—and shelled out a record amount of cash to do it.
Pharmamarketeer richt zich op marketingprofessionals van farmaceuten en andere medisch-gerelateerde organisaties in Nederland en België.
Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer
